Journal Information
Vol. 88. Issue S2.
Pages 19 (November - December 2022)
Share
Share
Download PDF
More article options
Vol. 88. Issue S2.
Pages 19 (November - December 2022)
Open Access
Susceptibility of the Swiss model to amicacine
Visits
1445
Maria Luiza Queiroz Sampaioa, Lucieny Silva Martins Serraa,
Corresponding author
lucienymserra@gmail.com

Corresponding author.
, Carla Giovanna Silva Borgesb, Natalia Lombardi Pessoab, André Luiz Lopes Sampaiob
a Universidade Católica de Brasília, Brasília, DF, Brazil
b Universidade de Brasília, Brasília, DF, Brazil
This item has received

Under a Creative Commons license
Article information
Special issue
This article is part of special issue:
Vol. 88. Issue S2
More info
Full Text

Amicacine causes irreversible ototoxicity and early detection of this disease is considered a difficult task. Clinical studies of the effects of amicacine in men have revealed that the drug can produce changes that cause tinnitus, hearing loss at high frequencies and behavioral manifestations. The anatomical–physiological equivalence of the peripheral auditory system of humans with mice causes this model of animal to be routinely used in clinical trials, as they contribute to the prevention, diagnosis and treatment of alterations caused by the use of this drug.

Objective: This study aimed to verify the susceptibility of the Murino Swiss model to external hair cell lesions caused by the use of aminoglycoside amiccin.

Method: Experimental, prospective and intervention research, approved by CEUA/UnB no. (63/2018). The animals were divided into two groups: control group (G1) and Ototoxic Amicacine (G2). G1 received sodium chloride (serum) solution 10mg/kg/day and G2 received amicacin 400mg/kg/day. The solutions were offered daily intraperitoneally for 14 consecutive days. Otoacoustic emissions were performed by distortion product at frequencies from 6 to 12kHz in T0 and T14 and histological study of the ymimpnanic leaflets were performed. The analyses were carried out using the Prism®5 program. Differences with p<0.05 were considered significant.

Results: The use of amicacin in a dose of 400mg/kg/day for 14 consecutive days did not cause damage to external snare cells and cochlear structures in the SWISS model.

Conclusion: Swiss mice have resistance to ototoxicity of amicacine under treatment at the dosage of 400mg/kg/day for 14 days intraperitoneally.

Keywords: Hearing loss; Choclea; Ototoxicity; Inner ear; Audiology; Amicacine.

Brazilian Journal of Otorhinolaryngology (English Edition)
Article options
Tools
Announcement Nota importante
Articles submitted as of May 1, 2022, which are accepted for publication will be subject to a fee (Article Publishing Charge, APC) payment by the author or research funder to cover the costs associated with publication. By submitting the manuscript to this journal, the authors agree to these terms. All manuscripts must be submitted in English.. Os artigos submetidos a partir de 1º de maio de 2022, que forem aceitos para publicação estarão sujeitos a uma taxa (Article Publishing Charge, APC) a ser paga pelo autor para cobrir os custos associados à publicação. Ao submeterem o manuscrito a esta revista, os autores concordam com esses termos. Todos os manuscritos devem ser submetidos em inglês.